Abstract
Reprogramming of human somatic cells into pluripotent cell types gives insight in the pathophysiology of diseases. We analysed genes recently shown to be differentially expressed in induced pluripotent stem cells (iPS) in 95 breast cancer samples. This analysis reveals two breast cancer subgroups with stem cell-like features, differing in ER-status and proliferation as well as in their clinical course of disease.
| Original language | English |
|---|---|
| Journal | European Journal of Cancer |
| Volume | 44 |
| Issue number | 13 |
| Pages (from-to) | 1789-1792 |
| Number of pages | 4 |
| ISSN | 0959-8049 |
| DOIs | |
| Publication status | Published - 09.2008 |
Funding
We thank Samira Adel and Katherina Kourtis for expert technical assistance. This work was supported by grants from the Deutsche Krebshilfe, Bonn, the Margarete Bonifer-Stiftung, Bad Soden, the BANSS-Stiftung, Biedenkopf and the Dr. Robert Pfleger-Stiftung, Bamberg.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Differentially expressed genes of reprogrammed human pluripotent stem cells in breast cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver